Definium Therapeutics, Inc. (DFTX) — Financial Flexibility Index
Definium Therapeutics, Inc. (DFTX) has a Financial Flexibility Index of -0.49x as of June 2026. Free cash flow of $-95.41 Million (operating CF $-95.41 Million minus capex $0.00) represents 0% of total liabilities ($194.22 Million). Check DFTX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Definium Therapeutics, Inc. Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Definium Therapeutics, Inc. across 11 annual periods. For the full cash flow conversion analysis, see DFTX cash generation efficiency.
Annual Financial Flexibility Index for Definium Therapeutics, Inc. (2015–2025)
Year-by-year free cash flow to debt coverage for Definium Therapeutics, Inc.. Explore Definium Therapeutics, Inc. (DFTX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.22x | $-131.56 Million | $-131.56 Million | $107.77 Million | ▲ +6.4% |
| 2024 | -1.30x | $-79.13 Million | $-79.13 Million | $60.70 Million | ▲ +6.0% |
| 2023 | -1.39x | $-64.36 Million | $-64.36 Million | $46.41 Million | ▲ +47.2% |
| 2022 | -2.63x | $-50.14 Million | $-50.14 Million | $19.08 Million | ▲ +29.2% |
| 2021 | -3.71x | $-45.82 Million | $-45.82 Million | $12.34 Million | ▲ +11.1% |
| 2020 | -4.18x | $-23.60 Million | $-23.60 Million | $5.65 Million | ▼ -888.7% |
| 2019 | 0.53x | $105.34K | $-208.12K | $198.96K | ▼ -98.6% |
| 2018 | 39.05x | $321.39K | $-722.45K | $8.23K | ▲ +111.8% |
| 2017 | 18.44x | $1.48 Million | $-665.98K | $80.44K | ▲ +40104.7% |
| 2016 | 0.05x | $3.46K | $-26.64K | $75.47K | ▲ +100.7% |
| 2015 | -6.22x | $-46.56K | $-46.56K | $7.49K | — |